Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04762771 · ClinicalTrials.gov registry record · Phase 1
Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)
A Phase 1 study, sponsored by Baptist Health South Florida.
- Terminated
- Registry status
- Phase 1
- Development phase
- 2
- Enrollment target
NCT04762771 is a Phase 1 study that was terminated before completion, run by Baptist Health South Florida. The registered enrollment target is 2 participants.
The verdict
NCT04762771, a Phase 1 study, was terminated before completion, sponsored by Baptist Health South Florida.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 2 participants
- Enrollment target
Study Summary
This is an open-label unblinded, randomized study to treat hospitalized covid-19 patients with colchicine plus current care (per institution treating physicians) vs. current care per institution treating physicians alone (the control arm)
Interventions
- DRUG Colchicine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-12-23 |
| Est. Completion | 2021-09-20 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04762771
The ClinicalTrials.gov registry entry for NCT04762771 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baptist Health South Florida, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Colchicine is the first listed.
NCT04762771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04762771 about?
NCT04762771 is a clinical study titled "Colchicine for the Treatment of Cardiac Injury in Hospitalized Patients With COVID-19 (COLHEART-19)". This is an open-label unblinded, randomized study to treat hospitalized covid-19 patients with colchicine plus current care (per institution treating physicians) vs. current care per institution treating physicians alone (the control arm)
What is the current status of trial NCT04762771?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 2 participants. The study started on 2020-12-23. Estimated completion is 2021-09-20.
What interventions are being tested in trial NCT04762771?
The interventions under investigation include: Colchicine (DRUG).
Who is sponsoring clinical trial NCT04762771?
This trial is sponsored by Baptist Health South Florida, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.